Other Affiliated Sites
开元体育(中国)官方网站
开元体育·(中国)官方APP下载
开元体育平台(中国)官方网站app下载
开元体育官网(中国)官方下载-IOS/安卓通用版/手机APP下载
开云app(中国)官方网站-ios/安卓版/手机版app下载
开云·APP官方入口(中国)官方网站-IOS/安卓通用版/手机app
开云·APP(kaiyun)(中国)官方网站-IOS/Android通用版/手机app下载
华体会·(HTH)官网APP下载 - Apple app store
江南体育·(中国)官方网站 - ios/安卓版/手机APP下载
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Preparations Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Prospectus
Announcements
2023.02.24
Overseas Regulatory Announcement
2023.02.24
Overseas Regulatory Announcement
2023.01.31
POSITIVE PROFIT ALERT ANNOUNCEMENT ON THE ESTIMATED INCREASE IN PROFIT FOR THE A...
2022.11.07
POLL RESULTS OF THE 2022 SECOND EXTRAORDINARY GENERAL MEETING HELD ON NOVEMBER 4...
2022.10.28
2022 THIRD QUARTERLY RESULTS
2022.10.14
DATE OF BOARD MEETING
2022.09.30
ANNOUNCEMENT PROPOSED ISSUANCE OF CORPORATE BONDS AND CHANGE IN USE OF PROCEEDS
2022.09.28
Notification Letter
2022.09.28
Interim Report 2022
2022.08.29
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2022
第一页
上一页
1
2
3
4
5
下一页
最后一页
